Steward Partners Investment Advisory’s Centessa Pharmaceuticals CNTA Stock Holding History

Steward Partners Investment Advisory’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-81	Closed	-$3.22K	–	4694
2026 Q1	$3.22K	Hold	81	–	–	﹤0.01%	3922
2025 Q4	$2.03K	Hold	81	–	–	﹤0.01%	3958
2025 Q3	$1.96K	Buy	+81	New	+$1.44K	﹤0.01%	3930

Steward Partners Investment Advisory's CNTA Position: Q2 2026 in Review

Steward Partners Investment Advisory sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 81 shares — an estimated $3.22K sold.

Steward Partners Investment Advisory first reported a position in CNTA in Q3 2025 and held it in 3 quarters. The position peaked at $3.22K in Q1 2026. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

Steward Partners Investment Advisory reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Steward Partners Investment Advisory sold 81 Centessa Pharmaceuticals shares in Q2 2026, an estimated $3.22K.
Steward Partners Investment Advisory first reported a position in Centessa Pharmaceuticals in Q3 2025 and held it in 3 quarters.
Steward Partners Investment Advisory's Centessa Pharmaceuticals position peaked at $3.22K in Q1 2026.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.